Search

Search Constraints

You searched for: Author/Creator Xavier, R

Search Results

1. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Issue 11 (November 2021)

2. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Issue 3 (4th June 2015)

3. OP01 In-depth characterisation of host genetics and gut microbiome unravels novel host–microbiome interactions in inflammatory bowel disease. (25th January 2019)

4. OP011 Integration of whole-exome sequencing and RNA sequencing of intestinal biopsies in inflammatory bowel disease identifies inflammation-dependent effects. (16th January 2018)

5. OP014 Analysis of 1792 gut metagenomes reveals microbial treatment targets for inflammatory bowel disease and irritable bowel syndrome. (16th January 2018)

6. P312 Combination corticosteroids with, 5-aminosalicylic acid versus corticosteroids alone in the treatment of hospitalized patients with acute severe ulcerative colitis: A multi-center randomized controlled trial. (21st January 2022)

8. P515 Manipulating the microbiome in paediatric acute severe colitis with a cocktail of antibiotics: A pilot randomised controlled trial. (16th January 2018)

9. P551 6-Thioguanine nucleotide levels are associated with mucosal healing in patients with Crohn's disease: A multi-centre, international study. (16th January 2018)

10. P572 Half of children with acute severe colitis have predominant single faecal bacterial species, mostly Escherichia coli: Microbiome results from the PRASCO trial. (25th January 2019)